Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Nardone

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|July 1, 2021
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint BlockadeValerio Nardone, Rocco Giannicola, Giovanna Bianco, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2021
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer)Maria Antonietta Mazzei, Letizia Di Giacomo, Giulio Bagnacci, et al.
Cureus|May 27, 2016
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic IrradiationValerio Nardone, Paolo Tini, Michelangelo Biondi, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk AssessmentGaetano Maria Russo, Anna Russo, Fabrizio Urraro, et al.
Translational Cancer Research|March 14, 2024
Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative reviewRuishan Wen, Xiulian Huang, Jinyu Long, et al.
Cancers|June 24, 2022
Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and SurgeryValerio Nardone, Alfonso Reginelli, Roberta Grassi, et al.
Medical Oncology (Northwood, London, England)|April 3, 2020
Delta-radiomics increases multicentre reproducibility: a phantom studyValerio Nardone, Alfonso Reginelli, Cesare Guida, et al.
Clinical Lung Cancer|November 1, 2025
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC StudyAlessio Bruni, Davide Franceschini, Beatrice Marini, et al.
Diagnostics (Basel, Switzerland)|November 27, 2025
Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial)Valerio Nardone, Vittorio Patanè, Luca Marinelli, et al.
The Journal of Liquid Biopsy|March 3, 2025
New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insightsMauro Buono, Gianluca Russo, Valerio Nardone, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|July 1, 2021
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint BlockadeValerio Nardone, Rocco Giannicola, Giovanna Bianco, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2021
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer)Maria Antonietta Mazzei, Letizia Di Giacomo, Giulio Bagnacci, et al.
Cureus|May 27, 2016
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic IrradiationValerio Nardone, Paolo Tini, Michelangelo Biondi, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk AssessmentGaetano Maria Russo, Anna Russo, Fabrizio Urraro, et al.
Translational Cancer Research|March 14, 2024
Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative reviewRuishan Wen, Xiulian Huang, Jinyu Long, et al.
Cancers|June 24, 2022
Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and SurgeryValerio Nardone, Alfonso Reginelli, Roberta Grassi, et al.
Medical Oncology (Northwood, London, England)|April 3, 2020
Delta-radiomics increases multicentre reproducibility: a phantom studyValerio Nardone, Alfonso Reginelli, Cesare Guida, et al.
Clinical Lung Cancer|November 1, 2025
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC StudyAlessio Bruni, Davide Franceschini, Beatrice Marini, et al.
Diagnostics (Basel, Switzerland)|November 27, 2025
Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial)Valerio Nardone, Vittorio Patanè, Luca Marinelli, et al.
The Journal of Liquid Biopsy|March 3, 2025
New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insightsMauro Buono, Gianluca Russo, Valerio Nardone, et al.
Pageof 14